Bolt Operating Margin from 2010 to 2024
| BOLT Stock | USD 0.76 0.01 1.30% |
Check Bolt Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bolt Biotherapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 6.5 M, Interest Income of 6.5 M or Depreciation And Amortization of 1.8 M, as well as many indicators such as Price To Sales Ratio of 5.11, Dividend Yield of 0.0 or PTB Ratio of 0.39. Bolt financial statements analysis is a perfect complement when working with Bolt Biotherapeutics Valuation or Volatility modules.
Bolt | Operating Margin |
Latest Bolt Biotherapeutics' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Bolt Biotherapeutics over the last few years. It is Bolt Biotherapeutics' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bolt Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (3.24) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Bolt Operating Margin Regression Statistics
| Arithmetic Mean | (117.50) | |
| Coefficient Of Variation | (51.65) | |
| Mean Deviation | 48.10 | |
| Median | (144.04) | |
| Standard Deviation | 60.69 | |
| Sample Variance | 3,684 | |
| Range | 203 | |
| R-Value | 0.65 | |
| Mean Square Error | 2,305 | |
| R-Squared | 0.42 | |
| Significance | 0.01 | |
| Slope | 8.78 | |
| Total Sum of Squares | 51,569 |
Bolt Operating Margin History
About Bolt Biotherapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Bolt Biotherapeutics income statement, its balance sheet, and the statement of cash flows. Bolt Biotherapeutics investors use historical funamental indicators, such as Bolt Biotherapeutics's Operating Margin, to determine how well the company is positioned to perform in the future. Although Bolt Biotherapeutics investors may use each financial statement separately, they are all related. The changes in Bolt Biotherapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bolt Biotherapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bolt Biotherapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bolt Biotherapeutics. Please read more on our technical analysis and fundamental analysis pages.
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California. Bolt Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 91 people.
Pair Trading with Bolt Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bolt Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Bolt Stock
| 0.76 | VRDN | Viridian Therapeutics Earnings Call This Week | PairCorr |
Moving against Bolt Stock
| 0.6 | PFE | Pfizer Inc Financial Report 6th of August 2024 | PairCorr |
| 0.54 | ELUT | Elutia Inc Symbol Change | PairCorr |
| 0.34 | MCRB | Seres Therapeutics | PairCorr |
| 0.32 | HOOK | Hookipa Pharma | PairCorr |
| 0.31 | GPCR | Structure Therapeutics | PairCorr |
The ability to find closely correlated positions to Bolt Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bolt Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bolt Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bolt Biotherapeutics to buy it.
The correlation of Bolt Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bolt Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bolt Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bolt Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.